Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

DCAP vs DGICB: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

DGICB Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 8–2 Matrix Metrics)

DGICB Overall Winner 6-Pillar Tally: DCAP 0 – 4 DGICB (2 Tie) Matrix Metrics: DCAP 2 – 8 DGICB

As of Nov 16, 2026, DGICB (DGICB) is the stronger overall head-to-head candidate over DCAP (DCAP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DCAP carries a Unified Composite Score of 47.1/100 (HOLD) at $24.22 (N/M Forward P/E, N/A operating margin), whereas DGICB carries 30.8/100 (SELL) at $28.55 (14.4x Forward P/E, 9.0% operating margin).

  • Composite vs. Pillar Nuance: While DCAP currently prints a higher short-term Unified Composite Score (47.1/100 HOLD vs. DGICB 30.8/100 SELL), DGICB captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (9.0% vs. N/A operating margin) and revenue trajectory (-3.4% vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DCAP vs DGICB
DCAP US Equity
DCAP
Institutional Equity
$24.22
-0.87% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.22β · 9% Vol
Unified Composite Score
47.1 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
DGICB US Equity Head-to-Head Winner
DGICB
Institutional Equity
$28.55
+1.21% 1D
Market Cap $1.1B
TTM Revenue $955M
Forward P/E 14.4x
Beta / 30D Vol 0.27β · 86% Vol
Unified Composite Score
30.8 / 100 SELL
Tech 5.0 Fund 27.0 Flow 50.0 Mom 31.5
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (4.2% over 20 days), RSI 67
RSI-14: 66.6 · SMA20: $25.16 · SMA50: $21.89

6-Pillar Scorecard Institutional Category Breakdown (DCAP 0 – 4 DGICB)

Columns: Metric · DCAP · DGICB
1. Valuation Multiples DGICB
Forward P/E N/M 14.4x
Trailing P/E N/M 15.2x
PEG Ratio N/M 1.90x
EV / Revenue N/M 1.1x
2. Growth & Scale DGICB
Revenue Growth (YoY) N/A -3.4%
Earnings Growth (YoY) N/A -11.3%
TTM Revenue (USD) N/A $955M
Market Cap N/A $1.1B
3. Profitability & Quality DGICB
Gross Margin N/A 9.2%
Operating Margin N/A 9.0%
Net Profit Margin N/A 7.2%
Return on Equity (ROE) N/A 10.7%
4. Balance Sheet & Cash Flow DGICB
Cash Generation (TTM) N/A $88M EBITDA
Cash Flow Margin N/A 9.2% EBITDA Mgn
Net Cash / Leverage N/A ROE $17.70 Book/Sh · 10.7% ROE
Dividend Yield None (0.00%) 2.69%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Insurance - Property & Casualty Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DCAP (2) vs DGICB (8)
Institutional Metric DCAP DGICB Criterion Row Edge
Market Capitalization
Scale
N/A $1.1B Larger Scale DGICB
Trailing P/E Ratio
Valuation
N/M 15.2x Lower Multiple DGICB
Forward P/E Ratio
Valuation
N/M 14.4x Lower Multiple DGICB
Revenue Growth (YoY)
Growth
N/A -3.4% Higher Growth DGICB
Operating Margin (TTM)
Profitability
N/A 9.0% Higher Margin DGICB
Net Profit Margin
Profitability
N/A 7.2% Higher Margin DGICB
Return on Equity (ROE)
Capital Efficiency
N/A 10.7% Higher ROE DGICB
52-Week Range Position
Momentum
0% ($24–$26) 91% ($14–$30) Stronger Trend DGICB
Beta / 30D Volatility
Risk Regime
0.22β · 9% Vol 0.27β · 86% Vol Lower Realized Risk DCAP
Unified Institutional Score
Composite Signal
47.1 / 100 (HOLD) 30.8 / 100 (SELL) Higher Composite DCAP
Trailing 12M Revenue (USD)
Operating Scale
N/A $955M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 9.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 1.90x PEG · 1.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) $88M EBITDA ($17.70 Book/Sh · 10.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon DGICB +52.59 pp
DCAP: -3.5% · DGICB: +49.09%
3M Horizon DGICB +67.39 pp
DCAP: -3.4% · DGICB: +63.99%
6M Horizon DGICB +67.39 pp
DCAP: -3.4% · DGICB: +63.99%
1Y Horizon DGICB +67.39 pp
DCAP: -3.4% · DGICB: +63.99%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DCAP vs DGICB. Trailing 12-month operating profitability (DCAP N/A vs DGICB 9.0%) and valuation multiples (DCAP N/M vs DGICB 14.4x Forward P/E) are benchmarked directly in Pillar 4 below.

DCAP ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
DGICB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$955M
Gross Margin9.2%
Op. Margin9.0%
ROE / Fwd P/E10.7% · 14.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DCAP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DCAP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
DGICB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DGICB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DCAP Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
DGICB Moat Profile Cyclical / Execution-Driven Positioning
Insurance - Property & Casualty Operator
Competes within the Insurance - Property & Casualty value chain with $1.1B market capitalization and 9.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ DCAP vs DGICB Key Questions & Quantitative Answers

As of Nov 16, 2026, DGICB (DGICB) is the stronger overall head-to-head candidate over DCAP (DCAP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DCAP carries a Unified Composite Score of 47.1/100 (HOLD) at $24.22 (N/M Forward P/E, N/A operating margin), whereas DGICB carries 30.8/100 (SELL) at $28.55 (14.4x Forward P/E, 9.0% operating margin). Composite vs. Pillar Nuance: While DCAP currently prints a higher short-term Unified Composite Score (47.1/100 HOLD vs. DGICB 30.8/100 SELL), DGICB captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (9.0% vs. N/A operating margin) and revenue trajectory (-3.4% vs. N/A YoY).

DGICB leads the Growth & Scale pillar: DCAP posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with DGICB at -3.4% YoY revenue growth and -11.3% YoY earnings growth on $955M TTM revenue (9.2% gross margin, 9.0% operating margin). On trailing 12-month operating scale, DCAP generates N/A in USD-normalized revenue versus $955M for DGICB. In operating R&D and SG&A reinvestment, DCAP deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for DGICB.

DGICB screens cheaper on headline valuation multiples. DCAP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas DGICB trades at 14.4x Forward P/E, 15.2x Trailing P/E, 1.90x PEG, and 1.1x EV/Revenue (9.2% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DCAP (N/A ROE) versus DGICB (10.7% ROE) capital efficiency.

In options market volatility and institutional positioning, DCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.22β · 9% Vol realized risk). By comparison, DGICB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.27β · 86% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.